Narcan Spray
Product Images NDC 69547-353

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Narcan (NDC 69547-353). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Emergent Devices Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Narcan 01

Chemical structure of Naloxone Hydrochloride, the active ingredient in Narcan nasal spray. The diagram shows the molecular framework including rings and functional groups typical to naloxone, along with the associated hydrochloride (HCl) component.*

FDA Label Image

Narcan 02

A line graph showing naloxone plasma concentration (mg/mL) over time (hours postdose) for different doses and routes of administration, including nasal sprays of varying concentrations and an intramuscular injection. The graph illustrates the rise and fall of naloxone levels up to 6 hours postdose with error bars for variability.*

FDA Label Image

Narcan 03

A line chart showing naloxone plasma concentration (ng/mL) over time (hours postdose) for different naloxone hydrochloride nasal spray and injection dosages. Concentration peaks within 0.25 hours for all forms, with different curves representing varying doses and administration routes.*

FDA Label Image

Narcan 04

Illustration depicting hands opening a foil pouch containing a nasal spray device, consistent with instructions for using Narcan (Naloxone Hydrochloride) nasal spray 4 mg/.1mL by Emergent Devices Inc.*

FDA Label Image

Narcan 05

An instructional diagram showing a hand holding a nasal spray device. The image highlights and labels the 'plunger' at the back and the 'nozzle' at the front of the spray device, illustrating how to correctly position the spray for use.*

FDA Label Image

Narcan 06

An instructional illustration showing the administration of Narcan nasal spray to a person. It depicts a hand holding the spray device near the nostril of a patient lying down, demonstrating proper nasal spray use.*

FDA Label Image

Narcan 07

An instructional diagram showing the proper use of a nasal spray. The image illustrates a hand holding the nasal spray device, administering the spray into a nostril of a person, demonstrating the correct angle and method of nasal application.*

FDA Label Image

Narcan 08

An instructional illustration showing a person positioned on their side with one hand supporting their head and the knee placed to prevent the body from rolling onto the stomach, demonstrating a safety or recovery posture.*

FDA Label Image

Narcan 09

Narcan Nasal Spray 2 mg packaging label by Emergent Devices Inc. The carton displays the product name, naloxone HCl as the active ingredient, nasal spray dosage form, and strength of 2 mg per 0.1 mL. The box contains four doses and includes opioid overdose response instructions with illustrations, storage information, and usage directions. The label also emphasizes checking the expiration date before use and notes nasal administration only.*

FDA Label Image

Narcan 10

Narcan 4 mg/0.1 mL Nasal Spray package carton for opioid overdose emergency treatment. The label shows the product name, active ingredient naloxone HCl, two 4 mg doses per box, use instructions with illustrations for nasal spray administration, storage warnings, and manufacturer Emergent Devices Inc. It includes a barcode and notes to check expiration and thaw instructions if frozen.*

FDA Label Image

Narcan 11

Label for Narcan nasal spray 4 mg, containing naloxone hydrochloride. The label shows the product's NDC number 69547-353-02 and indicates it is for nasal use only with one spray per device. It includes storage instructions, cautionary warnings, and manufacturer information for Emergent Devices Inc., Plymouth Meeting, PA. The label also features a barcode and lot/expiration date placeholders.*

FDA Label Image

Narcan 12

Quick start guide for Narcan (Naloxone Hydrochloride) Nasal Spray, 4 mg/.1mL, providing opioid overdose response instructions. The text outlines three key steps: identifying opioid overdose and checking for response, administering the nasal spray, and calling for emergency medical help while monitoring the person. Illustrated instructions accompany the text for ease of understanding. The labeler shown is Emergent Devices Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.